NutriBand (NTRB) Revenue (2018 - 2026)

NutriBand's (NTRB) quarterly Revenue came in at $400709.0 in Q1 2026, down 37.62% year-on-year from $642379.0 in Q1 2025, and up 15.79% quarter-over-quarter from $346058.0 in Q4 2025.

NutriBand (NTRB) Revenue (2018 - 2026) Analysis & Trends

NutriBand has disclosed Revenue across 9 years of filings, most recently posting $400709.0 for Q1 2026.

  • Revenue for Q1 2026 came in at $400709.0, down 37.62% year-over-year; the trailing twelve-month figure through Jan 2026 was $2.0 million (down 4.81% YoY), and the FY2026 annual result was $2.0 million, down 4.81% from the prior year.
  • Revenue came in at $400709.0 for Q1 2026 at NutriBand, up from $346058.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $667432.0 in Q2 2025 to a low of $346058.0 in Q4 2025.
  • The 5-year median for Revenue is $491890.0 (2022), against an average of $519588.3.
  • Across the five-year window, Revenue soared 118.35% in 2022 and slumped 46.41% in 2025, its largest moves.
  • NutriBand's Revenue stood at $618003.0 in 2022, then slumped by 30.77% to $427841.0 in 2023, then soared by 50.94% to $645796.0 in 2024, then plunged by 46.41% to $346058.0 in 2025, then rose by 15.79% to $400709.0 in 2026.
  • The last three Revenue figures came in at $400709.0 (Q1 2026), $346058.0 (Q4 2025), and $622452.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 5.21 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 306.30 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 2.99 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 NutriBand 41.91 Mn 37.33 Mn 88,941.00 400,709.00

Historic Data

Download Data
DateValue
Jan 31, 2026 400,709.00
Oct 31, 2025 346,058.00
Jul 31, 2025 622,452.00
Apr 30, 2025 667,432.00
Jan 31, 2025 642,379.00
Oct 31, 2024 645,796.00
Jul 31, 2024 442,830.00
Apr 30, 2024 408,532.00
Jan 31, 2024 524,613.00
Oct 31, 2023 427,841.00
Jul 31, 2023 655,928.00
Apr 30, 2023 476,932.00
Jan 31, 2023 527,535.00
Oct 31, 2022 618,003.00
Jul 31, 2022 456,149.00
Apr 30, 2022 477,922.00
Jan 31, 2022 491,890.00
Oct 31, 2021 283,037.00
Jul 31, 2021 213,739.00
Apr 30, 2021 433,488.00